Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Content Type

Project (15)
Report Summary (3)
Programme (9)

Language

English (25)

Advanced search

Results 1 - 10 of 27
Results/page:
12 3 > 
Application of omics-based strategies for improved diagnosis and treatment of endocrine hypertension
ID: 633983
Start date: 2015-05-01, End date: 2020-04-30
Arterial hypertension affects up to 45% of the general population and is responsible for 7.1 million deaths per year worldwide. Although a large therapeutic arsenal exists, blood pressure control is sub-optimal in up to two thirds of patients. Yet, even small increments in...
Programme: H2020-EU.3.1.2.
Record Number: 193266
Last updated on: 2017-02-14
Periodic Reporting for period 1 - ENSAT-HT (Application of omics-based strategies for improved diagnosis and treatment of endocrine hypertension)
Arterial hypertension affects up to 45% of the general population and is responsible for 7.1 million deaths per year worldwide. However, optimal blood pressure control is not being achieved in up to two thirds of patients. Endocrine forms (E) of high (H) blood pressure (BP...
Programme: H2020-EU.3.1.2.
Record Number: 198109
Last updated on: 2017-05-16
Towards the elimination of iodine deficiency and preventable thyroid-related diseases in Europe
ID: 634453
Start date: 2015-06-01, End date: 2018-05-31
Despite the fact that iodine deficiency (ID) can easily be prevented by iodine fortification of table salt, industrial salt and cattle food, Europe belongs to the worst regions in terms of access to iodized salt and is seriously ID, resulting in the perpetuation of the single...
Programme: H2020-EU.3.1.2.
Record Number: 193289
Last updated on: 2017-04-05
Periodic Reporting for period 1 - EUthyroid (Towards the elimination of iodine deficiency and preventable thyroid-related diseases in Europe)
Iodine deficiency is the world’s leading cause of preventable brain damage and for years the World Health Organization has warned that Europeans are increasingly affected by the consequences of iodine deficiency. Europe currently has no harmonised approach to ensure that the...
Programme: H2020-EU.3.1.2.
Record Number: 198275
Last updated on: 2017-05-18
Enhancing the effectiveness of programs and strategies to prevent youth smoking: a comparative realist evaluation of 7 European cities
ID: 635056
Start date: 2015-10-01, End date: 2018-09-30
Cigarette smoking is a main risk factor for premature disease, disability and death in Europe, especially in disadvantaged groups. Prevention of youth smoking is crucial to any strategy aimed at reducing this disease burden in the future. Several potentially effective...
Programme: H2020-EU.3.1.2.
Record Number: 193318
Last updated on: 2017-05-04
Optimizing a deployable high efficacy malaria vaccine
ID: 733273
Start date: 2017-01-01, End date: 2021-12-31
A highly effective malaria vaccine against Plasmodium falciparum should help prevent half a million deaths from malaria each year. New vaccine technologies and antigen discovery approaches now make accelerated design and development of a highly effective multi-antigen...
Programme: H2020-EU.3.1.2.
Record Number: 207225
Last updated on: 2017-04-19
European Human Biomonitoring Initiative
ID: 733032
Start date: 2017-01-01, End date: 2021-12-31
The overarching goal of the European Human Biomonitoring Initiative (HBM4EU) is to generate knowledge to inform the safe management of chemicals and so protect human health. We will use human biomonitoring to understand human exposure to chemicals and resulting health impacts...
Programme: H2020-EU.3.1.2.
Record Number: 207219
Last updated on: 2017-04-19
Development of Effective Vaccines against Multiple Lifecycle Stages of Plasmodium vivax malaria
ID: 733073
Start date: 2017-01-01, End date: 2021-12-31
Plasmodium vivax is the most widespread malaria and constitutes a significant proportion of human malaria cases. P. vivax accounts for 100-400 million clinical cases each year among the 2.5 billion people living at risk in Latin America, Oceania and Asia. The recently revised...
Programme: H2020-EU.3.1.2.
Record Number: 207218
Last updated on: 2017-04-19
Breast Cancer Risk after Diagnostic Gene Sequencing (BRIDGES)
ID: 634935
Start date: 2015-09-01, End date: 2020-08-31
Breast cancer affects more than 360,000 women per year in the EU and causes more than 90,000 deaths. Identification of women at high risk of the disease can lead to disease prevention through intensive screening, chemoprevention or prophylactic surgery. Breast cancer risk is...
Programme: H2020-EU.3.1.2.
Record Number: 193315
Last updated on: 2017-04-25
Screening to improve Health In very Preterm infantS in Europe
ID: 633724
Start date: 2015-09-01, End date: 2018-08-31
Very preterm birth is a principal determinant of motor and cognitive impairment in later life. About 50 000 infants in the EU survive very preterm birth annually and are at much higher risk of cerebral palsy, visual and auditory deficits, impaired cognitive ability...
Programme: H2020-EU.3.1.2.
Record Number: 193252
Last updated on: 2017-04-11
12 3 > 
List retrieved on: 2017-05-23
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top